Looking at the filing, I can see this is a Form 10-K for IBEX Limited. The cover page shows the trading symbol is "IBEX" on the "Nasdaq Global Market." The substantive disclosure content is sufficient to proceed.

IBEX Limited filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on September 10, 2026, covering the fiscal year ended June 30, 2026.

Key Highlights

  • Fiscal year covered: The annual report covers the period ended June 30, 2026.
  • Shares outstanding at December 31, 2025: 13,440,178 common shares were outstanding as of December 31, 2025, the last business day of the registrant's most recently completed second fiscal quarter.
  • Non-affiliate market value: The aggregate market value of voting and non-voting common equity held by non-affiliates as of December 31, 2025 was approximately $431,277,118, based on the closing sale price on that date as reported on the Nasdaq Global Market.
  • Shares outstanding at August 31, 2026: The registrant had 13,278,634 common shares outstanding as of August 31, 2026.
  • Filer status: The registrant is classified as an accelerated filer and is not a smaller reporting company, emerging growth company, or large accelerated filer.
  • Internal controls attestation: The registrant filed a report and attestation to management's assessment of the effectiveness of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act by its registered public accounting firm.

IBEX Limited Annual Disclosure: Shares, Market Value, and Filer Status for Fiscal Year Ended June 30, 2026

IBEX Limited, incorporated in Bermuda and headquartered at 1717 Pennsylvania Avenue NW, Suite 825, Washington, DC 20006, filed its annual report on NASDAQ:IBEX for the fiscal year ended June 30, 2026. The company's common shares, which carry a par value of $0.000111650536, are listed on the Nasdaq Global Market under the trading symbol IBEX, according to the filing's registered-securities table.

The filing discloses that as of December 31, 2025, the last business day of the registrant's most recently completed second fiscal quarter, 13,440,178 common shares were outstanding. The aggregate market value of voting and non-voting common equity held by non-affiliates on that date was approximately $431,277,118, based on the closing sale price on the Nasdaq Global Market. By August 31, 2026, the registrant reported 13,278,634 common shares outstanding, reflecting a reduction from the December 31, 2025 count.

According to the filing, IBEX Limited is classified as an accelerated filer and confirmed it is not a large accelerated filer, non-accelerated filer, smaller reporting company, or emerging growth company. The registrant also confirmed that its registered public accounting firm attested to management's assessment of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act. The filing contains forward-looking statements, which the company notes are subject to known and unknown risks and uncertainties, with cautionary language detailed under the "Risk Factors" section of the Form 10-K. The registrant indicated that portions of its definitive proxy statement relating to its next Annual Meeting of Shareholders are incorporated by reference in Part III of this annual report.

What Was Disclosed

IBEX Limited's Form 10-K for the fiscal year ended June 30, 2026 discloses share counts as of two dates, an approximate non-affiliate market capitalization of $431,277,118, accelerated filer status, and an attestation of internal control over financial reporting.